drugset / Trial / NCT07564466
A Study of SKB571 in Participants With Gastrointestinal Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability and preliminary anti-tumor activity of SKB571 in participants with gastrointestinal tumors.
Timeline
- Start
- 2026-06-30
- Primary completion
- 2027-08-31
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SKB571 | Unknown | — | Intravenous |